Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating Dermagraft for venous leg ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dermagraft (human fibroblast-derived dermal substitute)

Snippet

Sponsor: Organogenesis | Conditions: Venous Leg Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2013-02-04